Matthew R. Patterson

President & CEO, Audentes Therapeutics

Mr. Patterson is the co-founder of Audentes Therapeutics and has served as president and CEO since the Company’s inception in November 2012. He has more than 20 years of experience in the research, development, and commercialization of innovative treatments for rare diseases and has held positions of senior management in both private and public biotechnology companies. Previously Mr. Patterson worked for Genzyme Corporation, BioMarin Pharmaceutical, and Amicus Therapeutics. Prior to Audentes he was an Entrepreneur-In-Residence with OrbiMed, the world’s largest health-care dedicated investment firm.

Mr. Patterson is a member of the Board of Directors of Gilda’s Club of New York City, which provides social and emotional support for people living with cancer. He also currently serves as Vice Chairman of the Alliance for Regenerative Medicine (ARM). Mr. Patterson received his B.A. in Biochemistry from Bowdoin College.